- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06831162
다단계 건강 관련 사회 요구 이니셔티브의 효율성 평가
The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices.
The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.
연구 개요
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37203
- Vanderbilt University Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
ELIGIBILITY CRITERIA FOR EHR DATA EXTRACTION
Inclusion Criteria:
- 18 years of age or older
- Completed the health-related social needs (HRSN) screener as part of a primary care visit
- Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
Inclusion Criteria:
- 18 years of age or older
- Completed the HRSN screener as part of a primary care visit
- Diagnosed with type 2 diabetes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
- English-speaking
Exclusion Criteria:
- Blindness
- Hearing impairment
- Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)
- Being near the end of life (hospice or home hospice)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Multi-level HRSN initiative
Eligible patients will receive the HRSN initiative as part of their primary care appointments |
The multi-level health-related social needs (HRSN) initiative includes multiple components aimed at assessing and addressing HRSN in clinical practice: HRSN screening, EHR tools for clinical decision support, training and tools for health care providers to address HRSN, care coordinator support for patient outreach, and community resources for referral and support. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in glycemic control
기간: Baseline and 12 months post-baseline
|
Hemoglobin A1c extracted from the electronic health record where higher values indicate worse glycemic control. |
Baseline and 12 months post-baseline
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in cholesterol
기간: Baseline and 12 months post-baseline
|
Low-density lipoprotein (LDL) extracted from the electronic health record where higher values indicate worse hyperlipidemia. |
Baseline and 12 months post-baseline
|
|
Change in blood pressure
기간: Baseline and 12 months post-baseline
|
Systolic blood pressure extracted from the EHR where higher values indicate worse hypertension. |
Baseline and 12 months post-baseline
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in medication adherence (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the Adherence to Refills and Medications Scale-Diabetes (ARMS-D) with scores ranging from 11-44, where higher scores indicate more problems with medication adherence (worse). |
Baseline and 6 months post-baseline
|
|
Change in dietary behavior (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the short version of the Personal Diabetes Questionnaire scale (PDQ-11) Eating Behavior Problems subscale with scores ranging 1-6, where higher scores indicate more problem eating behaviors (worse). |
Baseline and 6 months post-baseline
|
|
Change in dietary behavior (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the short version of the Personal Diabetes Questionnaire scale (PDQ-11) Use of Information for Decision Making subscale with scores ranging 1-6, where higher scores indicate more use of dietary information for decision making (better). |
Baseline and 6 months post-baseline
|
|
Change in physical activity (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by scores on the Exercise Vital Sign (EVS) Tool with scores ranging 0-1,050 minutes or greater per week of moderate to strenuous physical activity. |
Baseline and 6 months post-baseline
|
|
Change in diabetes distress (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the Problem Areas in Diabetes-5 (PAID-5) scale with scores ranging from 0 to 20, where higher scores indicate greater diabetes-related emotional distress (worse). |
Baseline and 6 months post-baseline
|
|
Change in diabetes self-efficacy (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the Perceived Diabetes Self-Management Scale (PDSMS) with scores ranging 8 to 40, where higher scores indicate more self-efficacy (better). |
Baseline and 6 months post-baseline
|
|
Change in interpersonal processes of care (survey)
기간: Baseline and 6 months post-baseline
|
As assessed by the Interpersonal Processes of Care (IPC) survey with scores ranging from 1-5 (calculated as the mean of non-missing responses to the corresponding items), where higher scores indicate higher frequency of the labeled interpersonal process (e.g., decided together; lack of clarity). Scoring occurs for 7 interpersonal processes: lack of clarity; elicited concerns, responded; explained results; decided together; emotional support, compassion; discriminated due to race/ethnicity; and disrespectful office staff. |
Baseline and 6 months post-baseline
|
|
Change in perceived discrimination (survey)
기간: Baseline and 6 months post-baseline
|
As assessed on the Discrimination in Medical Settings scale with scores ranging from 7-35, where higher scores indicate higher frequency of experiences with discrimination in medical settings. |
Baseline and 6 months post-baseline
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Sunil Kripalani, MD, MSc, Vanderbilt University Medical Center
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 241778
- P50MD017347-03S3 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
After study results are posted on clinical trials and published, de-identified data will be available upon requests made to the principal investigator.
IPD 공유 기간
After study results are posted on clinical trials and outcomes published in a peer-reviewed journal, until 5 years later
IPD 공유 액세스 기준
Contact the principal investigator
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .